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Abstract
Background: In candidate-gene association studies of single nucleotide polymorphisms (SNPs), multilocus analyses
are frequently of high dimensionality when considering haplotypes or haplotype pairs (diplotypes) and differing
modes of expression. Often, while candidate genes are selected based on their biological involvement in a given
pathway, little is known about the functionality of SNPs to guide association studies. Investigators face the
challenge of exploring multiple SNP models to elucidate which variants, independently or in combination, might
be associated with a disease of interest. A data mining module, hapConstructor (freely-available in Genie software)
performs systematic construction and association testing of multilocus genotype data in a Monte Carlo framework.
Our objective was to assess its utility to guide statistical analyses of haplotypes within a candidate region (or
combined genotypes across candidate genes) beyond that offered by a standard logistic regression approach.
Methods: We applied the hapConstructor method to a multilocus investigation of candidate genes involved in
pro-inflammatory cytokine IL6 production, IKBKB, IL6, and NFKB1 (16 SNPs total) hypothesized to operate together
to alter colorectal cancer risk. Data come from two U.S. multicenter studies, one of colon cancer (1,556 cases and
1,956 matched controls) and one of rectal cancer (754 cases and 959 matched controls).
Results: HapConstrcutor enabled us to identify important associations that were further analyzed in logistic
regression models to simultaneously adjust for confounders. The most significant finding (nominal P = 0.0004; false
discovery rate q = 0.037) was a combined genotype association across IKBKB SNP rs5029748 (1 or 2 variant alleles),
IL6 rs1800797 (1 or 2 variant alleles), and NFKB1 rs4648110 (2 variant alleles) which conferred an ~80% decreased
risk of colon cancer.
Conclusions: Strengths of hapConstructor were: systematic identification of multiple loci within and across genes
important in CRC risk; false discovery rate assessment; and efficient guidance of subsequent logistic regression
analyses.
Background
In candidate gene association studies, multiple single
nucleotide polymorphisms (SNPs) selected to tag varia-
tion within a region or chosen based on previous
research are usually analyzed independently, in mul-
tiSNP haplotypes, and in multiSNP genotype combina-
tions across genes that may be functionally related.
Multi-locus analyses are often of high dimensiona-
lity, especially when considering whether to analyze
haplotype or diplotype data and differing modes of
expression, i.e. additive, dominant, or recessive. Studying
s u b s e t so fS N P su s i n gh a p C o n s t ructor, freely-available
software that performs a systematic and exhaustive con-
struction and testing of multilocus data in a Monte
Carlo framework, can guide these analyses to more
effectively define the haplotypes or combined genotypes
on which susceptibility variants reside [1,2]. As a novel
application of the hapConstructor method, we explored
multilocus associations in 16 tagging-SNPs across three
genes that are functionally related, I-Kappa-B Kinase-
Beta (IKBKB),I n t e r l e u k i n6( IL6), and Nuclear Factor
Kappa-B, Subunit 1 (NFKB1) in two multicenter U.S.
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these genes, SNPs were genotyped to comprehensively
tag genetic variation. Significant single SNP and multi-
SNP haplotype or combined genotype associations iden-
tified in hapConstructor were carried forward to logistic
regression models to simultaneously adjust for covari-
ates. The utility of hapConstructor to guide a multilocus
investigation is its integrated capability to systematically:
infer phase from genotype data, model all possible hap-
lotypes within genes, and model combined genotypes
across genes (for differing inheritance modes). Thus, the
potentially tedious process of setting up and evaluating
all possible multilocus analyses using procedures in sta-
tistical software (such as SAS or R) can be avoided.
The inflammatory process is thought to be a key
underlying component of colorectal cancer (CRC) that
is initiated by pro-inflammatory cytokines such as IL-6
in response to an inflammatory insult. IL-6 stimulates
secretion of C-reactive protein, an important biomarker
for pro-inflammatory status in several diseases, and
polymorphisms in the promoter region have been asso-
ciated with C-reactive protein circulating levels. We pre-
viously reported that variants in IL6,d b S N PI D
rs1800795 and rs1800796, were associated with reduced
risk of colon cancer among recent aspirin/nonsteroidal
anti-inflammatory drug (NSAID) users [3]; the
rs1800795 promoter SNP, which is in linkage disequili-
brium (LD) with rs1800797 (r
2 = 0.92), appeared to be
greatest for TP53 mutations while rs1800796 appeared
to influence all tumor types among NSAID users.
Although IKBKB and NFKB1 polymorphisms have not
been studied comprehensively with CRC, there is strong
evidence of their contribution to the inflammation pro-
cess. Nuclear transcription factor NF-Bi si n v o l v e di n
regulation of cytokines such as IL-6 [4]. In one study,
Landi, et al. evaluated a non-functional polymorphism
in NFKB1 and did not observe a significant association
with colon cancer [5].
To demonstrate its utility, we applied hapConstructor
in a multilocus mining of 4 candidate intronic SNPs
in IKBKB: rs2272733, rs3747811, rs5029748, and
rs10958713; 5 SNPs in IL6: rs1800796, rs1800797, and
rs2069827 (promoter); rs2069840 (intron), and rs2069860
(D162V); and 6 intronic SNPs in NFKB1: rs230510,
rs3821958, rs4648090, rs4648110, rs4648127, rs11722146,
and rs13117745 to comprehensively identify haplotype
and composite genotype subsets of these 16 candidate
inflammation-related loci associated with colon or rec-
tal cancer. Using hapConstructor individual and multi-
SNP results to focus our analyses, we further assessed
these associations in multivariate logistic regression
models, adjusting for potential confounders, in a large
U.S. multicenter study of colon cancer (1,556 cases and
1,956 matched controls) and of rectal cancer (754 cases
and 959 matched controls).
Methods
Study populations
Data for the study come from two case-control studies
that used identical methods to recruit and interview
study participants. Cases of first primary colon cancer
(ICD-O 2nd edition codes 18.0, 18.2-18.9) diagnosed
between 1 October, 1991 and 30 September, 1994 con-
ducted in the Northern California Kaiser Permanent
Medical Care Program (KPMCP), the Wasatch Front
area of Utah, and the Twin Cities Metropolitan area of
Minnesota were included in the first study. A subse-
quent study included incident cases diagnosed with a
first primary tumor in the rectosigmoid junction or rec-
t u mi d e n t i f i e db e t w e e nM a y1 9 9 7a n dM a y2 0 0 1i n
KPMCP and the state of Utah. Case eligibility was deter-
m i n e db yt h eS u r v e i l l a n c eE p i d e m i o l o g ya n dE n d
Results Cancer Registries in Northern California and in
Utah and the Minnesota Cancer Surveillance System
(colon cancer cases only). Case eligibility included being
between 30 and 79 years of age at the time of diagnosis,
English speaking, mentally competent to complete the
interview, no previous history of CRC, and no known
(as indicated on the pathology report or previous medi-
cal history) familial adenomatous polyposis, ulcerative
colitis, or Crohn’s disease. Of cases contacted, 83% par-
ticipated at KPMCP, 76% in Utah, and 67% in Minne-
sota. In the rectal cancer study, the participation rates
were 75% of cases from KPCMP and 70% of cases from
U t a h .T h es t u d i e sw e r ea p p r o v e db yt h eU n i v e r s i t yo f
Utah Institutional Review Board as well as Institutional
Review Boards at the Kaiser Permanente Medical Care
Program of Northern California (KPMCP) and the Uni-
versity of Minnesota.
Controls, subject to the same eligibility criteria as
cases, were frequency matched to cases by sex and by
5-year age cohort. At KPMCP, controls were randomly
selected from membership lists. In Utah, controls 65
years and older were randomly selected from lists pro-
v i d e db yt h eC e n t e r sf o rM e d i c a r ea n dM e d i c a i dS e r -
vices and controls younger than 65 were randomly
selected from driver’s license lists. In Minnesota, con-
trols were randomly selected from driver’s license lists.
Of controls contacted for the colon cancer study, 73%
participated at KPMCP, 53% participated from Minne-
sota and 69% participated from Utah. In the rectal can-
cer study, participation rates were 70% for KPMCP and
67% for Utah. The study populations have been pre-
viously described in detail [6,7]. Characteristics of
colon and rectal cancer study participants are shown
in Table 1.
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Trained and certified interviewers collected diet and life-
s t y l ed a t a[ 8 ] .T h er e f e r e n ty e a rf o rt h es t u d yw a st h e
calendar year approximately 2 years prior to date of
diagnosis (cases) or selection (controls). Information was
collected on demographic factors such as age, sex, and
study center; diet, physical activity, aspirin and non-ster-
oidal drug use, body size, and other lifestyle factors
including medical, family, and reproductive history. Par-
ticipants were asked to report their race/ethnicity; most
reported they were white, non-Hispanic (Table 1). The
data collection methods of these studies have been
detailed previously [6,7].
Genotyping
All markers were genotyped using a multiplexed bead
array assay format based on GoldenGate chemistry (Illu-
mina, San Diego, California). A genotyping call rate of
99.85% was attained. Two-hundred-fifty-three internal
replicates representing 4.4% of the sample set were
blinded and included. The duplicate sample genotype
concordance rate was 100.00% as determined by 350,070
matching genotypes among sample pairs.
Polymorphisms on the custom Illumina platform were
selected to account for genetic variation within each
candidate gene with redundant SNPs genotyped in most
tagging-SNP linkage disequilibrium bins. Of 7 markers
in IKBKB, one SNP failed genotyping, one SNP was
monomorphic in our study populations, and one SNP
failed Hardy-Weinberg equilibrium (HWE) testing
resulting in 4 SNPs carried forward to analysis. Of 6
markers in IL6, one SNP (rs1800795) was in high LD
with another promoter SNP (rs1800797) and was not
carried forward to analysis, resulting in 5 IL6 SNPs. Of
18 NFKB1 markers, one SNP failed genotyping, one very
rare SNP had a MAF < 0.01, and 9 SNPs were redun-
dant and well-represented by another binned tagging-
SNP with fewer missing values in the data (pairwise r
2 >
0.80); thus 7 SNPs were carried forward to analysis, for
a total of 16 SNPs. A description of genotyped markers
(in chromosome order) in IKBKB, IL6,a n dNFKB1
(including MAF and P-HWE) is shown in Additional
file 1. A total of 5,225 samples were successfully geno-
typed: 1,956 controls and 1,556 cases, colon study; 959
controls and 754 cases, rectal study.
Statistical methods
The hapConstructor 1.0 module of Genie 2.7.2.1, a
freely available software package [2], was used to com-
prehensively analyze multi-locus SNP haplotypes and
combined genotypes to identify associations with
affected status and assess their significance in a Monte
Carlo framework, as previously detailed [1]. Briefly, all
single SNP associations are tested independently. In
each subsequent forward step, a SNP is added to two-
locus through n-locus SNP sets whose test of association
of an empirical P-value exceeds a user-defined threshold
at the previous step. Rather than specify a significance
threshold that remained constant at each step, we
decided a priori to use successively more stringent
empirical P-value significance thresholds (10,000 simula-
tions), as the number of SNPs within each multilocus
subset was increased: 0.05, 0.01, 0.001 for single, two,
and three-locus sets, respectively; and 0.0001 for ≥ 4
locus sets. First, all single SNPs are tested for association
with colon and rectal cancer. For any SNP that reaches
as i n g l eS N PP-value threshold of 0.05, the second step
considers all 2-locus SNP sets containing the significant
SNP. Any 2-locus haplotypes or composite genotypes
that then surpass a 2-locus threshold of 0.01 are carried
f o r w a r dt oat h i r ds t e pw h i c hc o n s i d e r sa l l3 - l o c u sS N P
sets that include the two markers. Any 3-locus subsets
that surpass a threshold of 0.001 are carried forward to
an analysis of 4-locus subsets, and so forth until there
are no subsets that satisfy a subsequent threshold of
0.0001. This feature allows the user to alter the signifi-
cance level at each subsequent step, analogous to data
mining procedures used in SNP association studies such
as hill climbing that allow the “best” models to move
Table 1 Characteristics of colon cancer and rectal cancer
studies
Colon study Rectal study
Cases Controls Cases Controls
Characteristic n % n % n % n %
Total 1556 1956 754 959
Male 871 56.0 1047 53.5 451 59.8 541 56.4
Female 685 44.0 909 46.5 303 40.2 418 43.6
Age at diagnosis or
selection
30-39 23 1.5 40 2.0 19 2.5 21 2.2
40-49 102 6.6 128 6.5 96 12.7 101 10.5
50-59 290 18.6 326 16.7 196 26.0 243 25.3
60-69 538 34.6 673 34.4 250 33.2 329 34.3
70-79 603 38.8 789 40.3 193 25.6 265 27.6
Center
No. California (KPMCP) 744 47.8 787 40.2 480 63.7 594 61.9
Utah 250 16.1 378 19.3 274 36.3 365 38.1
Minnesota 562 36.1 791 40.4 0 - 0 -
White, non-Hispanic 1429 91.8 1828 93.5 625 82.9 824 85.9
White, Hispanic 59 3.8 75 3.8 61 8.1 63 6.6
Black 68 4.4 53 2.7 29 3.8 43 4.5
Asian 0 - 0 - 39 5.2 29 3.0
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zation [9,10]. More stringent P values with each pro-
gressive step also assured that multi-locus models were
adding statistically beyond significance observed for a
single SNP or combinations of SNPs from a previous
step, and multilocus models that achieve significance are
focused on those more likely to identify a significant
haplotype association or interaction across genes after
accounting for multiple comparisons. Thus, in our
genetic association investigation and in those of others
[11-13], we find increasing the stringency of the signifi-
cance level as the model becomes more complex is
appropriate in moving toward a more tractable solution
given the large number of comparisons.
For each gene, the full-length haplotype frequencies
were estimated from genotype data based on an expec-
tation-maximization algorithm [14], and the maximum
likelihood estimate haplotype pairs for each subject were
used for analysis. For two-locus haplotype combinations
from biallelic data, each set of 4 possible two-locus hap-
lotypes (assuming linkage equilibrium) is modeled as
additive, dominant, or recessive (12 haplotype tests). To
minimize inferred haplotypes from missing genotypes,
samples missing data in IKBKB, IL6,o rNFKB1 were
excluded from within-gene analyses and samples missing
any data for these 3 genes were excluded from analyses
across all markers. To avoid sparse cell sizes, hapCon-
structor examines composite genotypes modeled as
dominant and recessive, but not additive. Composite
genotype models include all dominant and recessive
combinations across loci; assuming linkage equilibrium,
4 composite genotypes can be tested across any two
SNPs: dominant/dominant, dominant/recessive, reces-
sive/dominant, or recessive/recessive. If the underlying
mode of inheritance is additive, a dominant model per-
forms adequately. Summaries of all tests were stored,
and a construction-wide false discovery rate (FDR) that
accounts for the multi-SNP process was generated, as
described [1]. All P-values for individual odds ratio test
statistics in hapConstructor were empirically derived
based on 10,000 simulations in the Genie null distribu-
tion as detailed previously [15]. Although the study
population was predominantly white and non-Hispanic,
separate genotype files by race/ethnicity to account for
allele frequency differences were incorporated using the
meta-analysis capabilities of Genie based on Cochran-
Mantel-Haenszel techniques as previously detailed [16].
SAS® statistical package, version 9.2 (Cary, N.C.) was
used to conduct logistic regression analyses to simulta-
neously consider covariates. Logistic regression models
were used to estimate odds ratios (OR) and 95% confi-
dence intervals (CI) for associations between indepen-
dent genotypes and multilocus SNP sets identified as
significantly associated in hapConstructor in colon or
rectal cancer. Logistic regression models were adjusted
for variables used to match controls to cases: age at
diagnosis or selection, state of residence (center), sex,
and race [17]. Additionally, logistic regression models
were adjusted for potential confounders: smoking, use of
nonsteriodal anti-inflammatory medications, body mass
index, and family history; however, these variables did
not substantively impact estimates, and thus were not
included. For gene-gene interaction logistic regression
models (Additional file 2), P for interaction was deter-
mined by comparing a full model including an ordinal
multiplicative interaction term to a reduced model with-
out an interaction term, using a likelihood ratio test
[18].
Results
Our findings from hapConstructor and logistic regres-
sion analyses are presented as follows: first, associations
of single SNPs analyzed independently; second, associa-
tions of multilocus haplotypes within each gene; third,
associations of multilocus composite genotypes across
genes including an illustration of the hapConstructor
method and its use in addressing multiple comparisons.
Single SNP results
In the hapConstructor analysis used to systematically
explore associations for haplotypes within IKBKB, IL6,
and NFKB1 and composite SNP genotypes across genes,
we generally observed similar associations for the same
single-locus SNPs significant at the 0.05 level in hap-
Constructor as for a logistic regression analysis of each
SNP considered independently (Table 2). In colon can-
cer, independent variant alleles in all three genes appear
to decrease risk of colon cancer. Conversely, in rectal
cancer, only NFKB1 SNPs were independently asso-
ciated, with 3 of 4 polymorphisms increasing risk. Addi-
tional file 1 includes a complete listing of ORs and 95%
CIs from logistic regression models for all independent
SNPs in IKBKB, IL6,a n dNFKB1 a n dr i s ko fc o l o na n d
rectal cancer, minimally adjusted for age, sex, race and
center.
Haplotype results
Any SNP identified as significantly associated with colon
and rectal cancer in the first step was then analyzed in
2-locus haplotypes with all other markers within IKBKB,
IL6,a n dNFKB1.W ed i dn o to b s e r v ea n yi n f o r m a t i v e
haplotypes within IKBKB or IL6 using hapConstructor
that were associated with colon cancer beyond the single
SNP results, nor in rectal cancer. Using hapConstructor,
we were able to identify significant 2-locus NFKB1 hap-
lotypes carried forward to subsequent logistic regression
analyses of cancer risk as shown in Table 3 by study, in
order of significance. Although hapConstructor is a data
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associations within candidate genes or regions, a deter-
mination by the researcher of the informativeness of any
haplotype of interest is nonetheless warranted. In rela-
tion to NFKB1 and risk of colon cancer, the most signif-
icant single locus identified in hapConstructor was
rs4648110 (Table 2). In significant two-locus models, a
second SNP, either rs230510 (A) or rs13117745 (T), was
carried in a haplotype with the rs4648110 minor allele
(Table 3). However, haplotype ORs did not differ sub-
stantively from the effect size of carrying variant
rs4648110 or rs13117745 alleles, when the SNP
genotypes were considered alone (P = 0.009; FDR q =
0.187). Pairwise correlation between this marker and
rs13117745 was r
2 = 0.71, and thus may be the same
association result with an underlying disease locus. Pair-
wise correlation between rs4648110 and rs230510 was
low (r
2 = 0.18), however carriage of the rs230510 major
Table 2 Single SNP results from hapConstructor and from multivariable-adjusted logistic regression
Genetic hapConstructor* Logistic regression**
Gene SNP Comparison Model OR P OR 95%CI
Colon study
IL6 rs2069860 AT/TT vs. AA Dominant 0.53 0.02 0.55 0.32, 0.95
IKBKB rs2272733 TT vs. CC Additive 0.55 0.02 0.56 0.34, 0.93
NFKB1 rs4648110 AA vs. TT Additive 0.63 0.01 0.65 0.44, 0.94
AA vs. TT/TA Recessive 0.64 0.01 0.66 0.45, 0.96
rs13117745 TT vs. CC Additive 0.61 0.03 0.61 0.37, 1.00
TT vs. CC/CT Recessive 0.62 0.04 0.64 0.39, 1.04
Rectal study
NFKB1 rs230510 TT vs. AA Additive 0.66 0.004 0.65 0.49, 0.87
TT vs. AA/AT Dominant 0.77 0.009 0.79 0.51, 0.94
rs3821958 GG vs. AA Additive 1.34 0.04 1.32 1.00, 1.75
rs11722146 GA/AA vs. GG Dominant 1.21 0.047 1.24 1.03, 1.51
rs13117745 TT vs. CC Additive 1.92 0.04 1.69 0.93, 3.07
NOTES: Odds ratios (ORs) compared to reference of major allele homozygotes; 95% confidence interval (95% CI)
*adjusted for race
**adjusted for age, sex, center, and race
Table 3 NFKB1 haplotypes and associations with colon and rectal cancer from hapConstructor and from multivariable-
adjusted logistic regression
Genetic hapConstructor* Logistic regression**
SNP 1 SNP 2 Haplotype Model OR P OR 95%CI
Colon study
rs230510 A > T rs4648110 T > A 2 copies A-A vs. 0/1 copy Rec. 0.62 0.009 0.65 0.45, 0.95
rs13117745 C > T rs4648110 T > A 2 copies T-A vs. 0 copies Additive 0.62 0.009 0.65 0.44, 0.94
Rectal study
rs3821958 A > G rs230510 A > T 2 copies A-T vs. 0 copies Additive 0.66 0.006 0.68 0.50, 0.91
rs4648127 C > T rs230510 A > T 2 copies C-T vs. 0 copies Additive 0.66 0.006 0.68 0.50, 0.91
rs11722146 G > A rs230510 A > T 2 copies G-T vs. 0 copies Additive 0.66 0.006 0.67 0.50, 0.90
rs13117745 C > T rs230510 A > T 2 copies C-T vs. 0 copies Additive 0.66 0.006 0.67 0.50, 0.90
rs230510 A > T rs4648090 G > A 2 copies T-G vs. 0 copies Additive 0.67 0.007 0.68 0.51, 0.90
rs11722146 G > A rs4648090 G > A 2 copies A-A vs. 0 copies Additive 1.47 0.007 1.47 1.11, 1.93
rs230510 A > T rs4648110 T > A 2 copies T-T vs. 0 copies Additive 0.68 0.009 0.68 0.51, 0.91
rs3821958 A > G rs4648110 T > A 2 copies G-A vs. 0 copies Additive 1.52 0.005 1.49 1.12, 1.99
rs11722146 G > A rs13117745 C > T 2 copies A-T vs. 0 copies Additive 1.51 0.005 1.53 1.16, 2.01
rs11722146 G > A rs4648127 C > T 2 copies A-T vs. 0 copies Additive 1.33 0.004 1.36 1.12, 1.65
rs3821958 A > G rs13117745 C > T 2 copies G-T vs. 0 copies Additive 1.53 0.003 1.52 1.13, 2.02
rs11722146 G > A rs4648110 T > A 2 copies A-A vs. 0 copies Additive 1.54 0.0028 1.55 1.17, 2.04
NOTES: Odds ratio (OR); 95% confidence interval (95% CI); Recessive (Rec)
*adjusted for race
**adjusted for age, sex, center, and race; all P-trends (additive model) were significant, <0.01
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did not substantively alter risk. Similarly in rectal can-
cer, the most significantly associated NFKB1 SNP,
rs230510, appears to independently contribute to
decreased risk with no additional information in terms
of either effect size or significance, conferred by a sec-
ond locus (Tables 2 and 3). The most nominally signifi-
cant 2-locus haplotype associated with rectal cancer
(P = 0.0028; FDR q = 0.074) was across rs11722146 and
rs4648110 (r
2 = 0.10) in which carrying two copies of
the minor alleles A-A confers a ~50% increased risk,
which is somewhat greater in effect than an OR of 1.2
when rs11722146 A allele was considered independently.
There were no haplotypes beyond the 2-locus step that
were significant at more stringent thresholds.
Composite genotype results
In complex disease pathways in which it is hypothe-
sized a number of genes of modest effect work
together to influence risk, composite genotypes across
markers residing on different chromosomes may be
important. Similar to hapConstructor steps outlined
above for investigating SNP haplotypes within genes,
markers across all three genes were analyzed jointly.
Any significant 2-SNP composite genotypes in hap-
Constructor are brought forward into an analysis of 3
SNPs etc., using successively more stringent signifi-
cance thresholds in each step. We were able to identify
genotype combinations that appear to influence risk of
colon and rectal cancer using hapConstructor for SNPs
across IKBKB, IL6,a n dNFKB1. In colon cancer, a two-
SNP composite genotype comprised of IL6 rs1800797
(dominant model) and NFKB1 rs4648110 (recessive
model) was significantly associated with 60% decreased
risk (P = 0.0004; FDR q = 0.037). At the three-locus
construction step, a combined genotype also including
NFKB1 rs13117745 was of the same magnitude in
effect, with a somewhat greater nominal significance
(P = 0.0002). The presence of LD between the two
NFKB1 markers (rs1311745 and rs4648110) in this
three-locus set was previously noted. The strongest
hapConstructor association (also significant after
accounting for multiple tests) was observed across all 3
inflammation-related genes, IKBKB (rs5029748) IL6
(rs1800797), and NFKB1 (rs4648110). Individuals with
1 or 2 minor alleles at rs5029748 and rs1800797, com-
bined with 2 minor alleles at rs4648110, had an almost
80% decreased colon cancer risk (P = 0.0004; FDR q =
0.037). Although this composite genotype profile was
relatively rare in our population (~1% of subjects), car-
riers of major alleles at these common loci appear to
be at greater risk of disease. There were no combina-
tions of ≥ 4 SNPs in colon study participants that met
hapConstructor significance thresholds.
In rectal cancer, only two-locus composite genotypes
across IKBKB and NFKB1,a n dIL6 and NFKB1 markers
met significance thresholds. The most significant find-
ings were IL6 rs1800797 (dominant model) and either
NFKB1 rs11722146 or rs3821958 (also modeled as
dominant). However, adjusting for multiple tests the
observed significance may represent a chance finding
(FDR q = 0.44). In terms of effect size, the odds ratios
do not differ substantively from single SNP results
although in logistic regression models adjusted for cov-
ariates, IKBKB rs3747811 and IL6 rs1800797 may miti-
gate increased risk of NFKB1. Informative composite
genotype models identified in hapConstructor were sub-
sequently analyzed in multivariate-adjusted logistic
regression models as highlighted in Table 4. Results of
logistic regression models including a multiplicative
interaction term for composite genotype associations
identified in hapConstructor (Table 4) are shown in
Additional file 2 to illustrate the utility of hapConstruc-
tor to prescreen significant SNP combinations that
inform more complicated analyses.
The hapConstructor method, applied to our analysis
of colon risk across genes, is illustrated in Figure 1. In
the first step, 4 single SNP associations were identified
that met a significance of 0.05, using a dominant, reces-
sive and additive genotype model for each of 16 SNPs
for a total of 47 tests (rs2069860 was not tested using a
recessive model because there were no rare-allele homo-
zygotes). These 4 SNPs were carried forward to step 2
and tested in 2-locus composite genotype models with
each other (6 comparisons) and all 12 SNPs remaining
(48 comparisons). Depending on allele frequencies and
the degree of LD between SNPs, not all 4 composite-
model combinations between two loci (dominant/
dominant, dominant/recessive, recessive/dominant, or
recessive/recessive) may have data. In our colon cancer
analysis, a total of 155 tests were performed at the
2-locus step out of a possible 216 tests. There were
3 models of 4 SNPs, in 2-locus combinations, significant
at the 0.01 level that were carried forward to step 3. At
the 3-locus step, 79 tests were performed out of a possi-
ble 312 tests (39 comparisons and a maximum of 8
composite genotype models, various combinations of
dominant or recessive at each of 3 SNPs). There were 3
models of 3-locus combinations, involving 5 SNPs,
which met a significance threshold of 0.001 and thus
were carried forward. At the 4-locus step, 68 tests were
performed out of 576 possible tests (36 comparisons
and a maximum of 16 composite genotype models).
There were no 4-locus results significant below 0.0001,
and thus hapConstructor did not continue further.
A total of 349 tests were performed in the multilocus
analyses of colon cancer across all three genes in hap-
Constructor as outlined, which resulted in 4 single-SNP
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a multivariable logistic regression. Absent a freely avail-
able and easy to implement systematic tool such as hap-
Constructor to guide our analysis of this pathway arm,
operator effort to similarly step through an exhaustive
analysis of possible combinations of loci under different
modes of inheritance would be required (Table 5).
Each multistep hapConstructor colon or rectal asso-
ciation haplotype analysis, using marker files stratified
by race/ethnicity, required ~30 minutes overall runtime
using Java 1.6 on a Dell Precision T5500 computer with
4 gigabytes of memory, using a Windows Vista Business
64-bit operating system. A composite genotype analysis
incorporating all 16 SNPs required ~90 minutes. Con-
struction-wide P-value assessment and determination of
an empirical FDR was considerably more time intensive
due to generation of 1,000 simulated datasets (each with
10,000 null simulations) which required an additional
15-20 hours to complete for a within-gene haplotype
analysis and 3-4 days to complete for the composite
genotype analysis across all SNPs.
Discussion
Proteins encoded by the genes selected for the analysis
were hypothesized as working together to influence col-
orectal cancer risk through an inflammation-related
pathway [19]. Binding of pro-inflammatory cytokines,
such as IL-6, to their receptors activate the NF-B com-
plex which in turn activates expression of cytokines and
cycloxygenase-2. Thus, NF-B is an important nuclear
transcription factor that regulates a large number of
cytokines and is critical for the regulation of inflamma-
tion; increased transcription of NF-B can increase
i n f l a m m a t i o na n da n g i o g e n e s i sa sw e l la sc e l ls u r v i v a l
and growth [20]. I-kappa-B kinase (IKK), which
phosphorylates I-kappa-B proteins, is a key regulator of
transcriptional activity of the NF-B complex [21]; IB
proteins are inhibitors of NF-B [20]. While the impor-
tance of the genes in the inflammation pathway has
been well documented, our study is the first to compre-
hensively examine polymorphisms in either NFKB1 or
IKBKB to identify functional polymorphisms associated
with colorectal cancer.
For independent SNP associations, we observed associa-
tions with IL6 and IKBKB in colon cancer but not rectal
cancer. NFKB1 SNPs appeared to be important in both
cancers, however the direction of risk differed with variant
alleles decreasing risk of colon cancer and, other than
rs230510, increasing risk of rectal cancer (Table 2). We
have previously reported associations in other genetic
polymorphisms, potentially modified by lifestyle and envir-
onmental factors, that appear to influence colon and rectal
cancer differentially [22-24], and thus these results are not
surprising. In our hapConstructor analysis, 2-locus haplo-
types within the NFKB1 gene were significant beyond sin-
gle SNP results (Table 3); however, after considering LD
between markers and adjusting for multiple comparisons,
it is unlikely that a haplotype represents an independent
finding beyond associations observed for single NFKB1
SNPs. In regard to composite genotype associations across
all 3 hypothesized inflammation-related genes (Table 4), of
interest is our observation that promoter variant IL6
rs1800797, while not independently associated, appears to
be working in concert with IKBKB and NFKB1 to influ-
ence risk of colon and cancer, even after multiple testing
is considered. This SNP is in high LD with a SNP in the
IL6 regulatory region (-572 G > C; rs1800795) that was
shown to functionally influence IL-6 expression and
increase CRP levels [25]; a potential glucocorticoid recep-
tor element exists nearby. As little is known about the
Table 4 Composite genotype associations with colon and rectal cancer from hapConstructor and from multivariable-
adjusted logistic regression
Genetic hapConstructor* Logistic regression**
SNP 1 SNP 2 SNP 3 SNP1/SNP2/SNP3 genotype Model OR P OR 95%CI
Colon study
IKBKB rs3747811 NFKB1 rs4648110 (TA or AA)/AA Dom./Rec. 0.56 0.0094 0.54 0.34, 0.87
IL6 rs2069827 NFKB1 rs4648110 (GT or TT)/AA Dom./Rec. 0.23 0.0058 0.21 0.06, 0.74
IL6 rs1800797 NFKB1 rs4648110 (GA or AA)/AA Dom./Rec. 0.41 0.0004 0.40 0.23, 0.72
IKBKB rs5029748 IL6 rs1800797 NFKB1 rs4648110 (CA or AA)/(GA or AA)/AA Dom./Dom./Rec. 0.21 0.0004 0.20 0.06, 0.67
IL6 rs1800797 NFKB1 rs4648090 NFKB1 rs4648110 (GA or AA)/(GA or AA)/AA Dom./Dom./Rec. 0.40 0.0004 0.40 0.21, 0.73
IL6 rs1800797 NFKB1 rs13117745 NFKB1 rs4648110 (GA or AA)/(GA or AA)/AA Dom./Dom./Rec. 0.39 0.0002 0.39 0.21, 0.73
Rectal study
IKBKB rs3747811 NFKB1 rs11722146 (TA or AA)/(GA or AA) Dom./Dom. 1.30 0.0096 1.11 0.83, 1.50
IL6 rs1800797 NFKB1 rs11722146 (GA or AA)/(GA or AA) Dom./Dom. 1.35 0.0068 1.38 1.04, 1.83
IL6 rs1800797 NFKB1 rs3821958 (GA or AA)/(AG or GG) Dom./Dom. 1.34 0.0044 1.15 0.85, 1.56
NOTES: Odds ratio (OR); 95% confidence interval (95%CI); Dominant (Dom); Recessive (Rec)
*adjusted for race; reference category is all other composite genotypes
**adjusted for age, sex, center, and race; reference category is major allele homozygote (dominant) or heterozygote (recessive) for each SNP
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findings will be taken forward to functionality testing. In
logistic regression analyses of composite genotypes, multi-
plicative P-interaction terms for SNPs across the pathway
were significant or borderline significant at the 0.05 level
in most models (Additional file 2), which supports the
hapConstructor finding of a joint effect.
The hapConstructor tool has been applied to the analy-
sis of haplotypes in recent candidate gene association stu-
dies [12,26,27]. In addition to haplotypes, an attractive
Figure 1 Illustration of the hapConstructor method and associations across IKBKB, IL6, and NFKB1 SNPs with risk of colon cancer.
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sively and systematically evaluate composite genotypes of
loci across multiple genes (Table 5). This feature is
potentially valuable for investigations of multiple genes
working together in candidate disease pathways, and our
findings represent a novel application of hapConstructor
in this regard; furthermore, it is not readily available in
standard logistic regression procedures (Table 5). As sig-
nificant SNP/SNP combinations are carried forward in
successive 1 to n-locus steps and tested against remaining
S N P s ,w ew e r ea b l et oe f f i c i e n t l yc a p t u r ea ni m p o r t a n t
composite gene association including an IL6 promoter
SNP (rs1800797) that was not independently associated
with colon or rectal cancer and may have otherwise been
missed in a traditional logistic regression framework. As
participants in our studies differed in race/ethnicity, we
were able to utilize the meta-analysis capabilities in
Genie software to appropriately assign different allele fre-
quencies to the Monte Carlo simulation of a null distri-
bution [16]. Although our study participants were
independent population-based cases and controls,
another strength is the ability of hapConstructor in the
Genie package to incorporate data of related individuals
in families or extended pedigrees instead of, or in addi-
tion to, unrelated cases and controls while providing
valid significance testing [15,16]. Another potential
strength is the ability to infer missing genotypes in hap-
Constructor, as the user can specify the amount of miss-
ing data allowed for each sample in haplotype estimation.
However, as our analysis also focused on multiSNP asso-
ciations across genes, inferring missing data from SNPs
on other chromosomes was not appropriate and thus
samples with missing genotypes were excluded.
A potential limitation of hapConstructor and Monte
Carlo testing in general is computational burden which
depends on number of SNPs under consideration, num-
ber of simulations (particularly in construction-wide
assessment of significance and generation of FDR), sam-
ple size, and threshold values for significance. In our
investigation of 16 loci using 10,000 simulations to pro-
vide empirical p-values in 5,225 total cases and controls,
hapConstructor runtimes were acceptable, but in other
situations may be considerable, depending on the num-
ber of genes and SNPs within genes. It is difficult to
quantify additional operator time required to set up all
possible multilocus haplotype models (within genes) and
combined SNP genotype models (across genes) for var-
ious modes of inheritance. Although not pre-integrated
into standard statistical packages, we acknowledge these
capabilities exist but require more programming time
for setup and analysis.
A multilocus mining method, hapConstructor is
dependent on user-specified significance thresholds in
successive 1 to n-locus steps. We chose to specify suc-
cessively more stringent significance thresholds begin-
ning with a nominal significance of 0.05 for single-locus
associations, 0.01 for two-locus associations, 0.001 for
three-locus associations, and 0.0001 for 4 or more loci
(minimum resolution given 10,000 simulations) to focus
on multilocus models that add to statistical significance
beyond single SNP associations or SNP combinations
identified in a previous step. Using a constant 0.05
threshold, we identified several multilocus associations
that met the threshold simply because a single SNP was
significant. By using successively more stringent signifi-
cance levels, we can target models for further investiga-
tion that are more likely to identify a true interaction.
Although the hapConstructor method can provide an
odds ratio statistic and a P for significance, it does not
simultaneously control for potential confounding
Table 5 Comparison of hapConstructor and logistic regression characteristics in multilocus modeling
Characteristic hapConstructor software Standard logistic regression
procedure
Stepwise logistic regression
procedure
Integrated phase estimation and building of
haplotypes from genotype data
Yes No; specialized software
required
No; specialized software
required
Systematically model all 2 to n-locus haplotypes within
a gene
Yes Yes, with additional
programming
Yes, with additional
programming
Systematically model mode of inheritance (dominant,
recessive, additive)
Yes Yes, with additional
programming
Yes, with additional
programming
Systematically model all SNP combinations across
genes
Yes No No
User-specified significance levels Yes; can vary for single
locus to n loci
Yes Yes
Model simultaneous covariates No Yes Yes
Multiple testing correction Yes (FDR) Yes (add-on procedure) Yes (add-on procedure)
Runtime (excluding additional operator programming
time)
Slow to adequate Fast Fast
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Page 9 of 11variables. We nonetheless found it to be a useful tool to
identify multilocus relationships for further analysis in a
multivariate logistic regression framework. We believe
the integrated capabilities of hapConstructor are most
useful when combined with subsequent logistic regres-
sion to refine risk estimates and corresponding confi-
dence intervals with adjustment for confounding
variables, and to further test for interaction among
significant multilocus associations identified in
hapConstructor.
The hapConstructor method represents a data mining
approach to directing a multiSNP investigation when
several genes and SNPs are involved, as in our applica-
tion. Other methods that reduce the dimensionality of
multiSNP analyses have been recently proposed. For
example, within a candidate region or gene of interest,
Yang, et al. describe a haplotype-based stepwise proce-
dure to eliminate extraneous SNPs in haplotype associa-
tion analysis [28] and others have proposed principal
components regression where multiple SNPs from the
candidate region tend to be correlated [29,30]. Other
methods have been proposed to test for potential gene-
gene interactions to identify specific locus combinations
of interest for further investigation, including extended
multifactor dimensionality reduction [31] or computa-
tionally-efficient algorithms for filtering these interac-
tions [32].
Conclusions
In conclusion, hapConstructor provided a useful tool to
systematically and comprehensively guide our explora-
tion of multilocus SNP combinations in three candidate
inflammation-related genes, IKBKB, IL6,a n dNFKB1 in
a U.S. case-control study of colon and rectal cancer.
Our findings suggest that polymorphisms in IKBKB, IL6,
and NFKB1 may jointly interact to influence colon and
rectal cancer risk through an inflammation-related path-
way. The utility of hapConstructor was further enhanced
by the capability of false discovery rate assessment to
account for multiple comparisons.
Additional material
Additional file 1: Description of candidate SNPs and association
with colon or rectal cancer. All genotyped SNPs (in chromosome
order) in IKBKB, IL6, and NFKB1 including their minor allele frequencies
and individual odds ratios (95%CIs) from logistic regression models for
risk of colon and rectal cancer.
Additional file 2: Composite genotype logistic regression model
associations with colon and rectal cancer identified in
hapConstructor. Results of logistic regression models including a
multiplicative interaction term for composite genotype associations
identified in hapConstructor.
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